Structural Study of Dihydrofolate Reductase-Thymidylate Synthase from Babesia bovis
Author Information
Author(s): Begley Darren W., Edwards Thomas E., Raymond Amy C., Smith Eric R., Hartley Robert C., Abendroth Jan, Sankaran Banumathi, Lorimer Donald D., Myler Peter J., deStaker Bart L., Stewart Lance J.
Primary Institution: Seattle Structural Genomics Center for Infectious Disease
Hypothesis
The structural characterization of dihydrofolate reductase-thymidylate synthase in Babesia bovis will reveal insights into its function and potential as a drug target.
Conclusion
The study provides structural insights into the dihydrofolate reductase-thymidylate synthase enzyme from Babesia bovis, highlighting its similarities to malaria enzymes and potential for drug design.
Supporting Evidence
- The study reveals structural similarities between the enzyme from Babesia bovis and those from malaria parasites.
- Antifolate drugs pemetrexed and raltitrexed were shown to bind to the enzyme, indicating potential for drug development.
- Understanding the enzyme's structure may help in designing treatments for babesiosis.
Takeaway
Scientists studied a protein from a parasite that causes a disease in cattle, hoping to find ways to make new medicines that can help treat infections in both animals and humans.
Methodology
The enzyme was expressed in E. coli, purified, and crystallized for structural analysis using X-ray diffraction.
Limitations
The study may not account for all possible mutations in the enzyme that could affect drug binding.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website